Cleared Traditional

K234013 - Mg OSTEOINJECT™ (FDA 510(k) Clearance)

Also includes:
Mg OSTEOREVIVE™ Mg OSTEOCRETE™
Feb 2024
Decision
48d
Days
Class 2
Risk

K234013 is an FDA 510(k) clearance for the Mg OSTEOINJECT™. This device is classified as a Filler, Bone Void, Calcium Compound (Class II - Special Controls, product code MQV).

Submitted by Bone Solutions, Inc. (Colleyville, US). The FDA issued a Cleared decision on February 5, 2024, 48 days after receiving the submission on December 19, 2023.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3045.

Submission Details

510(k) Number K234013 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 19, 2023
Decision Date February 05, 2024
Days to Decision 48 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code MQV - Filler, Bone Void, Calcium Compound
Device Class Class II - Special Controls
CFR Regulation 21 CFR 888.3045